Showing results (231-240 of 514) with videos related to

Sort By:
Pageof 52
Crohn'S & Colitis 360|August 29, 2024
Artificial Intelligence- and Physician-Interpreted Stool Image Characteristics Correlate With C-Reactive Protein Among Inpatients With Acute Severe Ulcerative Colitis: A Pilot StudySarah Rotondo-Trivette, Viankail Cedillo Castelan, Kushagra Mathur, et al.
Crohn'S & Colitis 360|September 30, 2024
A Comparative Analysis of Clinical Symptoms and Modified Pouchitis Disease Activity Index Among Endoscopic Phenotypes of the J Pouch in Patients With Inflammatory Bowel DiseaseShintaro Akiyama, Nathaniel A Cohen, Jacob E Ollech, et al.
Crohn'S & Colitis 360|September 16, 2024
Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global StudyRaja Atreya, Isabel Redondo, Petra Streit, et al.
Crohn'S & Colitis 360|May 9, 2025
Questionnaire Survey of Japanese Patients With Inflammatory Bowel Disease and Physicians on Shared Decision-Making in Advanced Therapy: A Web-Based PAIR SurveyFumihito Hirai, Takayuki Matsumoto, Keita Imai, et al.
Crohn'S & Colitis 360|May 5, 2025
The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug MonitoringRobert Gilmore, Richard Fernandes, Tamar Schildkraut, et al.
Crohn'S & Colitis 360|April 22, 2025
Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease PatientsKhaled Alsabbagh Alchirazi, Osama Hamid, Thabet Qapaja, et al.
Crohn'S & Colitis 360|April 14, 2025
Patients' Attitudes to Magnetic Resonance Imaging in Perianal Fistulizing Crohn's Disease: A Global SurveyEasan Anand, Jalpa Devi, Anna Antoniou, et al.
Crohn'S & Colitis 360|April 15, 2025
Investigation and Analysis of Frailty and Nutritional Status in Patients With Inflammatory Bowel DiseaseJin-Feng Liu, Qiu-Xia Jiang, Juan Liu, et al.
Crohn'S & Colitis 360|March 26, 2025
Correction to: Upadacitinib in Patients With Difficult-to-Treat Crohn's Disease
Crohn'S & Colitis 360|June 3, 2024
Safety and Effectiveness of Ustekinumab for Crohn's Disease With Perianal Manifestations: Ad hoc Analysis Data From 1-Year Post-Marketing Surveillance Study in JapanKatsumasa Nagano, Hiroaki Tsuchiya, Teita Asano, et al.
Pageof 52